Rumor Mill News Forum MOTOROLA -PACKARD - MASS PRODUCING BIO-CHIPS Posted By: Agent 777 <[EMAIL PROTECTED]> Date: Monday, 15 May 2000, at 11:44 a.m. MOTOROLA -PACKARD - MASS PRODUCING BIO-CHIPS Psychops Research Links www.osti.gov/biochip.htm http://209.145.38.129/psychops/Research_Links/research_links.html This site reveals that the U.S. Department of Energy's Argonne National Laboratory announced June 29, 1998 a joint-research project with Motorola Inc. and Packard Instrument Company "which aims at commercializing and marketing advanced biochips and related analytical technologies...." Take note--this partnership of powers was "announced" June 29, 1998. At this posting (Oct. 1999), that was over a year and three months ago. Just think of the research that had to have preceeded this agreement in order for these three entities to have formed this partnership. You'll see the site states "Motorola will develop manufacturing processes to mass produce biochips, and Packard will develop and manufacture the analytical instruments to process and analyze the biochips." Take note--MASS PRODUCE BIOCHIPS. The United States government has entered into an agreement with two publicly held corporations to MASS PRODUCE BIOCHIPS and no one has informed the American public! The site further states, "Argonne's contribution, in conjunction with its Moscow research partner the Russian Academy of Science's Engelhardt Institute of Molecular Biology, is intellectual property in the form of 19 inventions related to biological microchips." The irony here is that our government has been co-inventing technology with RUSSIA that we, the American people, can not get information on because it is classified under of National Security! Take note when you read "The Argonne/Engelhardt biochips employ a novel "micro-gel" technology in which as many as 10,000 micro-structures are mounted on a single glass surface about the size of a microscopic slide." What they are not telling you is that this "micro-gel", aka the biochip, can be put into a liquid and injected into a human body via an injection--a flu shot, any childhood immunization, etc. This site promotes "the great diagnostic powers this technology will bring to fields as diverse as medicine and environmental restoration," but fails to inform the reader of hidden dangers. The site makes reference to the Russian Human Genome Program and the Department of Energy's Human Genome Program. According to a biologist who works on the Department of Energy's Genome Program, part of the project's "research" includes experimenting on the general public with aireal spraying. For more information on how this aireal spraying ties in with the biochips, refer to the information contained in the video and audios listed in the products section. PARTNERSHIP TO DEVELOP BIOCHIP TECHNOLOGY http://www.osti.gov/biochip.htm Motorola, Packard Instrument Co. and Argonne to develop advanced biochip technology http://www.anl.gov/OPA/news98/news980629.htm ARGONNE, Ill. (June 29, 1998) -- Rapid advances in medicine, health care and agriculture are expected from a joint-research project announced today byMotorola Inc.,Packard Instrument Company and the U.S. Department of Energy's Argonne National Laboratory. The project, which aims at commercializing and marketing advanced biochips and related analytical technologies, is expected to make the process of decoding genes, human or otherwise, a thousand times faster than with current technologies. Motorola will develop manufacturing processes to mass produce biochips, and Packard will develop and manufacture the analytical instruments to process and analyze the biochips. Argonne's contribution, in conjunction with its Moscow research partner the Russian Academy of Science's Engelhardt Institute of Molecular Biology, is intellectual property in the form of 19 inventions related to biological microchips. Motorola and Packard will contribute a total of $19 million over five years to support the joint-research agreement, making it one of the largest biotechnology joint-research agreements ever signed by a U.S. Department of Energy laboratory. Argonne's 19 inventions, which have been licensed exclusively to Motorola and Packard, are the result of more than $10 million in research support since 1994 by the U.S. Department of Energy, theDefense Advanced Research Projects Agency, the Russian Academy of Sciences, and the Russian Human Genome Program. "With a commercial biochip to rapidly and economically perform genetic analysis, within a few years we should see better pharmaceuticals developed more rapidly, faster and more accurate medical diagnostics, a heightened ability to assess and possibly repair environmental damage, and better, more hardy, and healthier crops," said Richard McKernan, president of Packard Instrument Company. "This process, developed for the Department of Energy's human genome program, provides miniaturized, faster and more economical methods to analyze DNA samples," said Secretary of Energy Federico Pe�a. "Today's announcement is a recognition of the great diagnostic powers this technology will bring to fields as diverse as medicine and environmental restoration." Like computer chips, which perform millions of mathematical operations a second, biochips can perform thousands of biological reactions, such as decoding genes, in a few seconds. The Argonne/Engelhardt biochips employ a novel "micro-gel" technology in which as many as 10,000 micro-structures are mounted on a single glass surface about the size of a microscopic slide. Each micro-gel is like a micro-test tube in which chemical compounds can be tested against biological targets to provide answers to questions about DNA sequence, genetic variation, gene expression, protein interaction and immune response. In addition to being faster than conventional gene sequencing methods, these biochips provide a 3-dimensional platform that allows greater sensitivity and accuracy in assaying proteins, RNA and DNA. "Instead of reading DNA one letter or word at a time, they read whole phrases and sentences at a time," said Andrei Mirzabekov, a biologist whose research at Argonne and Engelhardt developed the biochips. "It's like speed-reading the genetic code with one hundred percent comprehension. "By combining biochips with robots and computers," Mirzabekov said, "we can find one genetic variation among three billion DNA bases in a matter of minutes. Conventional methods take days." A DNA base is one of the four biological molecules that link together to form DNA's well-known "double-helix" molecule. "Over the next four or five years, we plan to develop and refine the technology to mass produce biochips," said Rudyard L. Istvan, Motorola vice president and corporate director of strategy. "This should reduce their cost and make them widely available to genetic researchers in many fields." "Packard is known throughout the pharmaceutical and life sciences markets for providing innovative tools to speed drug discovery research," said McKernan. "As part of this team, we will develop the analytical instrumentation needed to use and process biochips." This biotechnology will have myriad applications in life science, including medical diagnostics, drug discovery, environmental restoration and agriculture. Medical diagnostics is where the greatest impact is expected. Medical and biological researchers will be able to identify in minutes mutated genes that could lead to later medical problems, such as cancer, multiple sclerosis or Alzheimer's. Widespread use of biochips will also remove the guesswork from early treatment of many diseases and conditions. By using less than a drop of test solution, doctors will be able to predict drug efficacy, to diagnose drug resistance to treatment for diseases such as AIDS and tuberculosis, and to make on-the-spot identification of specific bacteria, viruses, and other micro-organisms. Faster drug discovery and improved medical treatmentwill result from the ability to identify target genes and test new drugs and treatments far more rapidly for possible genetic impact. Bioassays that determine whether a drug causes genetic mutations or has other hazardous effects can be completed in days, rather than weeks or months. The use of biochips is also expected to speed up the regulatory drug approval process by classifying patient population based on genetic makeup. Faster progress in life-sciences research will result. For example, the regulation of gene expression, which takes months to study with conventional sequencing techniques, can be accomplished in a single, parallel experiment with this biochip technology. Faster and more effective environmental restoration will result from the ability to use biochips as highly sensitive detectors of microbial or organic pollution. Biochips may also help identify genes that enable some natural enzymes to detoxify chemicals and digest pollutants. Once identified, these environmentally friendly genes can be transferred into common bacteria to help clean up contaminated earth or water. Improved agricultural products will result from the ability to quickly and accurately detect agricultural disease and mutation, and to speed tests of the safety of new agricultural products. For example, genes that help plants resist mold can be identified and transferred to crops attacked by mold. Motorola is one of the world's leading providers of wireless communications, semiconductors and advanced electronic systems, components and services. Major equipment businesses include paging and data communications, cellular telephone, two-way radio,personal communications, automotive, defense and space electronics and computers. Motorola semiconductors power communications devices, computers and millions of other products. Motorola's 1997 sales were $29.8 billion. Packard Instrument Company is a subsidiary of Packard BioScience Company, a privately held company based in Meriden, Conn. Packard develops, manufactures and distributes innovative, high-quality analytical instrumentation, liquid-handling robots, and reagents. A premier supplier to the world's leading pharmaceutical and biotechnology companies, Packard provides the tools to make the search for cures for diseases faster, safer and more cost effective. With more than 200 different programs in basic and applied research, Argonne is one of the nation's largest federally funded scientific laboratories. Argonne is is operated by the University of Chicago for the U.S. Department of Energy. For more information, please contact: For Argonne Catherine Foster 630/252-5580 [EMAIL PROTECTED] For Packard Mary Ann Dostaler 860/688-5452 [EMAIL PROTECTED] For Motorola Kerry Kelly Cunningham Communication Inc. 617/374-4254 [EMAIL PROTECTED] <A HREF="http://www.ctrl.org/">www.ctrl.org</A> DECLARATION & DISCLAIMER ========== CTRL is a discussion & informational exchange list. Proselytizing propagandic screeds are unwelcomed. Substance�not soap-boxing�please! These are sordid matters and 'conspiracy theory'�with its many half-truths, misdirections and outright frauds�is used politically by different groups with major and minor effects spread throughout the spectrum of time and thought. That being said, CTRL gives no endorsement to the validity of posts, and always suggests to readers; be wary of what you read. CTRL gives no credence to Holocaust denial and nazi's need not apply. Let us please be civil and as always, Caveat Lector. ======================================================================== Archives Available at: http://home.ease.lsoft.com/archives/CTRL.html <A HREF="http://home.ease.lsoft.com/archives/ctrl.html">Archives of [EMAIL PROTECTED]</A> http:[EMAIL PROTECTED]/ <A HREF="http:[EMAIL PROTECTED]/">ctrl</A> ======================================================================== To subscribe to Conspiracy Theory Research List[CTRL] send email: SUBSCRIBE CTRL [to:] [EMAIL PROTECTED] To UNsubscribe to Conspiracy Theory Research List[CTRL] send email: SIGNOFF CTRL [to:] [EMAIL PROTECTED] Om
